Long-term treatment results and the immunoglobulin G subclass distribution patterns of proteinase-3-antineutrophil cytoplasm antibody (ANCA) and myeloperoxidase-ANCA in ANCA-associated vasculitis

被引:2
|
作者
Almroth, Gabriel [1 ]
Berlin, Gosta [2 ]
Andersson, Bengt [3 ]
Hahn-Zoric, Mirjana [3 ]
机构
[1] Linkoping Univ Hosp, Dept Nephrol, SE-58185 Linkoping, Sweden
[2] Linkoping Univ Hosp, Dept Clin Immunol & Transfus Med, SE-58185 Linkoping, Sweden
[3] Sahlgrens Univ Hosp, Dept Clin Immunol, S-41345 Gothenburg, Sweden
来源
关键词
ANCA; associated vasculitis; cyclophosphamide; IgG subclasses; MPO-ANCA; plasmapheresis; PR3-ANCA; pulse treatment; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; RENAL-DISEASE; HEPATITIS-B; AUTOANTIBODIES; ANTIGENS; EFFICACY; THERAPY;
D O I
10.1080/00365590802519354
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. Small vessel vasculitis associated with antibodies to neutrophil cytoplasm antigens has been denominated antineutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV). Material and methods. Ninety-eight patients with various forms of AAV with renal involvement were studied retrospectively with regard to treatment, side-effects and outcome. The immunoglobulin G (IgG) subclass distribution patterns in serum were determined in 51 patients with nephelometry and those of anti-proteinase-3 (PR3) and anti-myeloperoxidase (MPO) in 44 patients by enzyme-linked immunosorbent assay. Results. Fifty-nine patients with a mean age of 63 years were given treatment with intermittent intravenous regimens of cyclophosphamide and continuous corticosteroids, whereas 39 patients with a mean age of 58 years were given continuous oral treatment. Malignancy, mainly due to skin tumours, was more common in AAV than in the general population. The total IgG subclass distribution pattern was asymmetric. The response to PR3 was of IgG1, IgG3 and IgG4 isotypes, while IgG1 and IgG3 predominated in the response to MPO. Conclusion. The aberrant IgG subclass distribution pattern detected in the autoantibodies may be of importance in the pathogenesis of AAV.
引用
收藏
页码:160 / 170
页数:11
相关论文
共 50 条
  • [41] LONG-TERM EFFICACY AND SAFETY OF RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS: RESULTS FROM A UK TERTIARY REFERRAL CENTRE
    Pearce, Fiona
    Lanyon, Peter
    [J]. RHEUMATOLOGY, 2014, 53 : 184 - 184
  • [42] PROPYLTHIOURACIL-INDUCED VASCULITIS ASSOCIATED WITH ANTINEUTROPHIL ANTIBODY AGAINST PROTEINASE 3 (PR3-ANCA): A CASE REPORT
    Wang, X.
    [J]. RESPIROLOGY, 2011, 16 : 34 - 34
  • [43] Long-term outcome of severe alveolar hemorrhage in ANCA-associated vasculitis: A retrospective cohort study
    Hruskova, Z.
    Casian, A.
    Konopasek, P.
    Svobodova, B.
    Frausova, D.
    Lanska, V.
    Tesar, V.
    Jayne, D.
    [J]. PRESSE MEDICALE, 2013, 42 (04): : 752 - 752
  • [44] Predictors of long-term (≥ 5 year) renal survival in 535 patients with ANCA-associated vasculitis
    Berden, Annelies
    Flossmann, Oliver
    Westman, Kerstin
    Hoglund, Peter
    Hagen, E. Christiaan
    le Cessie, Saskia
    Walsh, Michael
    Bruijn, Jan Anthonie
    Jayne, David
    Bajema, Ingeborg
    [J]. APMIS, 2009, 117 : 150 - 150
  • [45] PULMONARY FIBROSIS IN ANCA-ASSOCIATED VASCULITIS: CLINICAL CHARACTERISTICS AND LONG-TERM FOLLOWUP OF 49 PATIENTS
    Comarmond, C.
    Crestani, B.
    Tazi, A.
    Hervier, B.
    Marchand, S. Adam
    Nunes, H.
    Cohen-Aubart, F.
    Wislez, M.
    Cadranel, J.
    Housset, B.
    Lloret-Linares, C.
    Seve, P.
    Pagnoux, C.
    Abad, S.
    Camuset, J.
    Bienvenu, B.
    Duruisseaux, M.
    Hachulla, E.
    Arlet, J. -B.
    Hamidou, M.
    Mahr, A.
    Resche-Rigon, M.
    Brun, A. -L.
    Grenier, P.
    Cacoub, P.
    Saadoun, D.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 553 - 554
  • [46] Long-term outcome of patients with severe renal ANCA-Associated vasculitis treated with plasma exchange
    Vankova, Z.
    Rihova, Z.
    Rysava, R.
    Jancova, E.
    Koupilkova, P.
    Mokrejsova, M.
    Lachmanova, J.
    Merta, M.
    Mareckova, H.
    Tesar, V.
    [J]. BLOOD PURIFICATION, 2007, 25 (04) : 341 - 341
  • [47] RECOVERY AND LONG-TERM RENAL OUTCOME OF PATIENTS WITH ANCA-ASSOCIATED VASCULITIS WHO ARE ON DIALYSIS AT PRESENTATION
    Lee, Y. J.
    Ahn, S. M.
    Hong, S.
    Oh, J. S.
    Lee, C. K.
    Yoo, B.
    Kim, Y. G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 916 - 917
  • [48] Long-term outcome of severe alveolar haemorrhage in ANCA-associated vasculitis: a retrospective cohort study
    Hruskova, Z.
    Casian, A. L.
    Konopasek, P.
    Svobodova, B.
    Frausova, D.
    Lanska, V.
    Tesar, V.
    Jayne, D. R. W.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2013, 42 (03) : 211 - 214
  • [49] THE LONG-TERM RENAL OUTCOME IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS: PREDICTIVE VALUE OF KIDNEY BIOPSY
    Biriukova, Ludmila
    Stolyarevich, Ekaterina
    Frolova, Nadia
    Artyukhina, Ludmila
    Tomilina, Natalia
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [50] Azathioprine as compared to cyclophosphamide maintenance therapy for ANCA-associated vasculitis is associated with increased long-term relapse risk
    不详
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (03): : 195 - 195